Cadence Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-5,716
| Closed | -$795K | – | 655 |
|
|
2018
Q3 | $795K | Sell |
5,716
-988
| -15% | -$137K | 0.04% | 433 |
|
|
2018
Q2 | $832K | Buy |
6,704
+82
| +1% | +$10.2K | 0.05% | 419 |
|
|
2018
Q1 | $738K | Buy |
6,622
+620
| +10% | +$69.1K | 0.05% | 438 |
|
|
2017
Q4 | $718K | Buy |
6,002
+1
| +0% | +$120 | 0.05% | 432 |
|
|
2017
Q3 | $842K | Buy |
+6,001
| New | +$842K | 0.05% | 411 |
|
|
2015
Q1 | – | Sell |
-12,903
| Closed | -$2.39M | – | 664 |
|
|
2014
Q4 | $2.39M | Sell |
12,903
-5,940
| -32% | -$1.1M | 0.14% | 200 |
|
|
2014
Q3 | $3.13M | Sell |
18,843
-11,157
| -37% | -$1.85M | 0.16% | 166 |
|
|
2014
Q2 | $4.69M | Buy |
+30,000
| New | +$4.69M | 0.22% | 149 |
|
|
2014
Q1 | – | Sell |
-34,939
| Closed | -$4.64M | – | 682 |
|
|
2013
Q4 | $4.64M | Sell |
34,939
-22,210
| -39% | -$2.95M | 0.18% | 247 |
|
|
2013
Q3 | $6.64M | Buy |
57,149
+13,339
| +30% | +$1.55M | 0.23% | 199 |
|
|
2013
Q2 | $4.04M | Buy |
+43,810
| New | +$4.04M | 0.19% | 217 |
|